EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis: Implications for diagnostic performance

Selin Kankaya iD, Metehan Karatas, Engin Hatipoglu, Nuray Kepil, Zulal Kaptan, Zeynep Caliskan, Matem Tuncdemir, Yildiz Dincer

PLOS One · 12.08.2026 · 21 (8) · e0335832

DOI: 10.1371/journal.pone.0335832 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS One, online erschienen am 12.08.2026. Verfasst von Selin Kankaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, Istanbul Yeni Yuzyil University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms, DNA Methylation, Promoter Regions, Genetic, Cysteine Dioxygenase. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Üniversitesi-Cerrahpasa, Tubitak, T.C. Istanbul Yeni Yuzyil University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silencing of the Cysteine dioxygenase-1 (CDO1) tumor suppressor gene by aberrant DNA methylation contributes to gastric carcinogenesis. Despite evidence that Helicobacter pylori (H. pylori) infection induces aberrant DNA methylation in the gastric mucosa, CDO1 promoter methylation has not been well characterized in H. Pylori positive (HPP) patients with chronic gastritis. This study aimed to investigate the CDO1 promoter methylation levels in patients with chronic gastritis with and without H. pylori infection, in comparison with gastric tumors. The quantitative analysis of CDO1 promoter methylation and CDO1 immunopositivity was performed in 45 primary gastric tumors, 17 biopsy samples of HPP chronic gastritis, 23 H. Pylori negative (HPN) chronic gastritis, and 15 normal gastric mucosa samples (control group). CDO1 expression was evaluated by immunohistochemistry, and promoter methylation levels were determined using quantitative methylation-specific PCR following bisulfite conversion. CDO1 promoter methylation levels were significantly higher in the gastric cancer (GC) group compared to the HPN chronic gastritis and control groups (p < 0.001). No significant difference was observed between the GC and HPP chronic gastritis groups. However, CDO1 promoter methylation levels were significantly higher in the HPP group compared to the HPN group (p = 0.049). No significant differences in CDO1 immunopositivity were observed among the study groups. ROC analysis demonstrated good discriminative ability of CDO1 methylation between GC and non-cancer cases (AUC = 0.83), whereas its performance was more limited in distinguishing GC from HPP chronic gastritis (AUC = 0.67). CDO1 promoter methylation is increased in GC and HPP chronic gastritis, suggesting that H. pylori -associated chronic inflammation may be associated with early epigenetic alterations. Although no direct correlation with protein expression was observed, our findings suggest that while CDO1 methylation may be informative for identifying cancer-related epigenetic changes, it may be insufficient as a standalone biomarker in high-risk inflammatory conditions. Further studies are needed to clarify its clinical utility, particularly in high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDNA MethylationPromoter Regions, GeneticCysteine DioxygenaseGastritisHelicobacter pyloriHelicobacter InfectionsHumansFemaleChronic DiseaseMiddle AgedMaleAgedGastric MucosaAdult

Substanzen

Cysteine DioxygenaseCDO1 protein, human

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Medicine, Istanbul Yeni Yuzyil University, Istanbul, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Surgical Medical Sciences, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pathology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Physiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Selin Kankaya

Förderung

  • Istanbul Üniversitesi-Cerrahpasa
  • Tubitak
  • T.C. Istanbul Yeni Yuzyil University

Zitieren

APA

Kankaya, S., Karatas, M., Hatipoglu, E., Kepil, N., Kaptan, Z., Caliskan, Z., Tuncdemir, M., & Dincer, Y. (2026). A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis: Implications for diagnostic performance. PLOS One, 21(8), e0335832. https://doi.org/10.1371/journal.pone.0335832

Vancouver

Kankaya S, Karatas M, Hatipoglu E, Kepil N, Kaptan Z, Caliskan Z, et al. A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis: Implications for diagnostic performance. PLOS One. 2026;21(8):e0335832. doi:10.1371/journal.pone.0335832

BibTeX
@article{Kankaya2026,
  author = {Kankaya, Selin and Karatas, Metehan and Hatipoglu, Engin and Kepil, Nuray and Kaptan, Zulal and Caliskan, Zeynep and Tuncdemir, Matem and Dincer, Yildiz},
  title = {A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis: Implications for diagnostic performance},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0335832},
  doi = {10.1371/journal.pone.0335832}
}
Kostenlos starten →